Results 1 to 10 of about 998,171 (180)

Memory B cells and CD8⁺ lymphocytes do not control seasonal influenza A virus replication after homologous re-challenge of rhesus macaques. [PDF]

, 2011
This study sought to define the role of memory lymphocytes in the protection from homologous influenza A virus re-challenge in rhesus macaques. Depleting monoclonal antibodies (mAb) were administered to the animals prior to their second experimental ...
Carroll, Timothy D, Fritts, Linda, Matzinger, Shannon R, McChesney, Michael B, Miller, Christopher J   +4 more
core   +17 more sources

2020–2021 rhinovirus genetic diversity in Saint Petersburg

Инфекция и иммунитет, 2023
Introduction. Rhinoviruses represent one of the most common respiratory viruses and belong to the Picornoviridae family, genus Enterovirus, being divided into three types: A, B, C, which account for 169 types.
Andrey D. Ksenafontov, Maria M. Pisareva, Veronika A. Eder, Tamila D. Musaeva, Artem V. Fadeev, Andrey B. Komissarov, Irina V. Kiseleva, Dmitry A. Lioznov   +7 more
doaj   +1 more source

Immunograph-based analysis of the influenza a(H1N1)pdm09 vaccine strain immunogenicity in the pandemic and post-pandemic period (2009–2014)

Инфекция и иммунитет, 2021
Currently, the assessment of the immunogenic properties of influenza viruses as a part of influenza vaccines is carried out by using seroprotection, seroconversion as well as the rate of increases in post-vaccination antibodies.
V. S. Vakin, I. V. Amosova, E. M. Vojcekhovskaya, T. A. Timoshicheva, A. A. Vasileva, M. G. Pozdnyakova, L. V. Lyalina, V. A. Marchenko, I. Yu. Nikonorov, M. P. Grudinin   +9 more
doaj   +1 more source

Evaluation of the Preventive Effectiveness of Influenza Vaccines in the Epidemic Season 2019–2020 in St. Petersburg

Эпидемиология и вакцинопрофилактика, 2021
Background. The vaccine is the best available instrument to prevent influenza and reduce the risks of major disease complications and mortality. The vaccine effectiveness during the influenza season depends on a number of factors: (1) a person vaccinated
M. K. Erofeeva, M. A. Stukova, E. V. Shakhlanskaya, Zh. V. Buzitskaya, V. L. Maksakova, T. I. Krainova, M. M. Pisareva, A. B. Popov, M. G. Pozdnjakova, D. A. Lioznov   +9 more
doaj   +1 more source

GENETIC AND ANTIGENIC CHARACTERISTICS OF RESPIRATORY SYNCYTIAL VIRUS STRAINS ISOLATED IN ST. PETERSBURG IN 2013-2016

Вопросы вирусологии, 2017
Antigenic and genetic characteristics of Russian RSV isolates are presented for the first time. Of the 69 strains isolated in St. Petersburg, 93% belonged to the RSV-A antigenic group.
V. Z. Krivitskaya, K. S. Sintsova, E. R. Petrova, M. V. Sverlova, E. V. Sorokin, T. R. Tsareva, A. B. Komissarov, A. V. Fadeev, M. M. Pisareva, Zh. V. Buzitskaya, V. S. Afanaseva, V. F. Sukhovetskaya, A. A. Sominina   +12 more
doaj   +1 more source

TIV vaccination modulates host responses to influenza virus infection that correlate with protection against bacterial superinfection [PDF]

, 2019
Background: Influenza virus infection predisposes to secondary bacterial pneumonia. Currently licensed influenza vaccines aim at the induction of neutralizing antibodies and are less effective if the induction of neutralizing antibodies is low and/or the
Choi, Angela, Christopoulou, Ioanna, García-Sastre, Adolfo, Saelens, Xavier, Schotsaert, Michael   +4 more
core   +2 more sources

Evaluation of the preventive effectiveness of influenza vaccines in St. Petersburg

Эпидемиология и вакцинопрофилактика, 2020
Background. The influenza vaccination coverage has steadily increased in the Russian Federation. The introduction of new domestic influenza vaccines into practice and the study of their effectiveness are of great importance for public health.
M. K. Erofeeva, M. A. Stukova, E. V. Shakhlanskaya, Zh. V. Buzitskaya, V. L. Maksakova, T. I. Krainova, T. M. Chirkina, M. M. Pisareva, D. A. Lioznov   +8 more
doaj   +1 more source

SAFETY AND IMMUNOGENICITY OF COLD-ADAPTED RECOMBINANT INFLUENZA VECTOR EXPRESSING ESAT-6 AND AG85А ANTIGENS OF M. TUBERCULOSIS

Вопросы вирусологии, 2017
Recombinant viral vectors represent one of the most promising platforms for creating a new generation of vaccines against tuberculosis. We constructed a vaccine candidate based on a cold-adapted influenza vector with a truncated NS1 protein containing an
M. V. Sergeeva, A. A. Pulkina, K. A. Vasiliev, E. A. Romanovskaya-Romanko, A. B. Komissarov, O. A. Kuchur, A. Yu. Egorov, L. M. Tsybalova, M. A. Stukova   +8 more
doaj   +1 more source

Assessment of the humoral immune response in children after immunization with different types of inactivated influenza vaccines in the 2019-2020 season

Медицинская иммунология, 2023
Causing millions of cases worldwide every year, influenza is one of the most common respiratory infections. The effectiveness of influenza vaccination and the nature of the resulting immune response may vary depending on the vaccine composition and age ...
Zh. V. Buzitskaya, A. B. Popov, E. A. Romanovskaya-Romanko, M. V. Sergeeva, E. A. Varyushina, M. K. Erofeeva, M. A. Stukova, D. A. Lioznov   +7 more
doaj   +1 more source

Features of Epidemic Process of Influenza and its Etiology in the Countries of the Northern and Southern Hemispheres in the Period of Circulation of Pandemic Virus A(H1N1)pdm09 (According to WHO)

Эпидемиология и вакцинопрофилактика, 2020
Relevance. Influenza is characterized by global distribution and the difference in its seasonality in countries with temperate and tropical climates. The importance of studying antigenic variation of influenza viruses due to the fact that changes in the ...
L. S. Karpova, M. Yu. Pelikh, N. M. Popovtseva, T. P Stolyarova, K. M. Volik   +4 more
doaj   +1 more source